Skip to content

Comapring impact of Bles versus Curosurf in respiratory distress of preterm infants

clinical trial for comparing impact of Bles versus Curosurf in management of respiratory distress syndrome in preterm neonates hospitalized in neonatal intensive care unit

Status
Active, not recruiting
Phases
Phase 3
Study type
Interventional
Source
IRCT
Registry ID
IRCT2017021418994N3
Enrollment
240
Registered
2017-04-07
Start date
2016-06-22
Completion date
Unknown
Last updated
2018-02-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Respiratory Dystress Syndrome. Hyaline membrane disease

Interventions

Intervention 1: Advising Cursourf with 2.5 cc/kg slowly via neonatal trachea with vital sign control and cardiopulmonary monitoring. Intervention 2: Advising Bles 5 cc/kg rapidly via neonatal trachea
Treatment - Drugs
Advising Cursourf with 2.5 cc/kg slowly via neonatal trachea with vital sign control and cardiopulmonary monitoring
Advising Bles 5 cc/kg rapidly via neonatal trachea with vital sign control and cardiopulmonary monitoring

Sponsors

Vice Chancellor of Kerman University of Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: Inclusion criteria: less than 34 weeks gestational age; Confirmed Respiratory Distress Syndrome Exclusion Criteria: Confirmed Sepsis; Congenital heart diseases; Pulmonary hemorrhage; Congenital Pneumonia

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

MeasureTime frame
Oxygenic Index. Timepoint: Before and 12 hours after intervention. Method of measurement: According ABG and ventilator indices.;Ventilation period. Timepoint: Before and 12 hours after intervention. Method of measurement: Neonates medical records.;NCPAP period. Timepoint: before and 12 hours after Intervention. Method of measurement: Neonates medical records.;Hospitalization time. Timepoint: After Intervention. Method of measurement: Neonates medical records.

Secondary

MeasureTime frame
Mortality rate. Timepoint: Before and 12 hours after intervention. Method of measurement: medical folder of neonates.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactDr Zeinab Kheradmand

Kerman University of Medical Sciences

vcr@kmu.ac.ir+98 34 3132 5700

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026